Extracts of Cynomorium songaricum protect human neuroblastoma cells from β-amyloid25-35 and superoxide anion induced injury

Pharmazie

Volumn 64, Issue 9, 2009, Pages 609-612

  Lu, Y ^a,b   Wang, Q ^a   Melzig, M F ^b   Jenett Siems, Kristina ^b  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID ETHYL ESTER; AMYLOID BETA PROTEIN[25-35]; CYNOMORIUM SONGARICUM EXTRACT; DICHLOROMETHANE; HYPOXANTHINE; METHANOL; NEUROPROTECTIVE AGENT; PLANT EXTRACT; SUPEROXIDE; UNCLASSIFIED DRUG; XANTHINE OXIDASE;

ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; ARTICLE; CELL DEATH; CELL PROTECTION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYNOMORIUM; CYNOMORIUM SONGARICUM; DRUG EFFECT; DRUG MECHANISM; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; NERVE CELL NECROSIS; NEUROBLASTOMA; NEUROBLASTOMA CELL; NEUROPROTECTION; OXIDATIVE STRESS;

ACETATES; AMYLOID BETA-PEPTIDES; CELL LINE, TUMOR; CELL SURVIVAL; CYNOMORIUM; HUMANS; METHANOL; NEUROPROTECTIVE AGENTS; OXIDANTS; PEPTIDE FRAGMENTS; PLANT EXTRACTS; SOLVENTS; SUPEROXIDES; XANTHINE OXIDASE;

EID: 75749101066     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2009.9610     Document Type: Article

References (22)

1. Atwood CS, Obrenovich ME, Liu T, Chan H, Perry G, Smith MA, Martins RN (2003) Amyloid-β: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-β. Brain Res Rev 43: 1-16.
2. rd, Beer B, Lippa AS (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217: 408-414.
3. Behl C, Moosmann B (2002) Antioxidant neuroprotection in Alzheimer's disease as preventive and therapeutic approach. Free Radic Biol Med 33: 182-191.
4. Benoit JN, Taylor MS (1997) Vascular reactivity following ischemia/reperfusion. Frontiers Biosci 2: e28-33.
5. Beyer G, Melzig MF (2003) Effect of selected flavonoids and caffeic acid derivatives on hypoxanthine-xanthine oxidase induced toxicity in cultivated human cells. Planta Med 69: 1125-1129.
6. Beyer G, Melzig MF (2005) Effect of propolis on hypoxanthine-xanthine oxidase-induced toxicity in cultivated human cells and on neutrophil elastase activity. Biol Pharm Bull 28: 1183-1186.
7. Chiou WF, Lee WS, Yeh PH (2006) Tetrandrine selectively protects against amyloid-β protein - but not against MPTP-induced cytotoxicity in SK-N-SH neuroblastoma cells. Planta Med 72: 1300-1304.
8. Christen Y (2000) Oxidative stress and Alzheimer disease. Am J Clin Nutr 71: 621S-629S.
9. Chu Q, Tian X, Lin M, Ye J (2006) Electromigration profiles of Cynomorium songaricum based on capillary electrophoresis with amperometric detection. J Agric Food Chem 54: 7979-7983.
10. Eckert A, Marques CA, Keil U, Schuessel K, Mueller WE (2003) Increased apoptotic cell death in sporadic and genetic Alzheimer's disease. Ann NY Acad Sci 1010: 604-609.
11. Jiang ZH, Tanaka T, Sakamoto M, Jiang T, Kouno I (2001) Studies on a medicinal parasitic plant: Lignans from the stems of Cynomorium songaricum. Chem Pharm Bull 49: 1036-1038.
12. Lu Y, Wang Q, Melzig MF, Jenett-Siems K (2009) Extracts of Cynomorium songaricum protect SK-N-SH human neuroblastoma cells against staurosporine-induced apoptosis potentially through their radical scavenging activity. Phytother Res 23: 257-261.
13. Ma C, Jian S, Zhang Y, Sun T (1992) Triterpenes and other constituents from Cynomorium songaricum. Chinese Chem Lett 3: 281-282.
14. Ma C, Nakamura N, Miyashiro H, Hattori M, Shimotohno K (1999) Inhibitory effects of constituents from Cynomorium songaricum and related triterpene derivatives on HIV-1 protease. Chem Pharm Bull 47: 141-145.
15. Markesbery WR (1997) Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 23: 134-147.
16. Mosmann T (1983) Rapid colorimetric assay of cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth 65: 55-63.
17. Pappolla MA, Sos M, Omar RA, Bick RJ, Hickson-Bick DL, Reiter RJ, Efthimiopoulos S, Robakis NK (1997) Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide. J Neurosci 17: 1683-1690.
18. Pike CJ, Burdick D, Walencewicz AJ, Glabe CG, Cotman CW (1993) Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. J Neurosci 13: 1676-1687.
19. 25-35 region to aggregation and neurotoxicity. J Neurochem 64: 253-265.
20. Qi Y, Su GE (1999) Progress in the research of Cynomorium (Cynomorium songaricum). Zhongcaoyao 31: 146-148.
21. Yatin SM, Varadarajan S, Butterfield DA (2000) Vitamin E prevents Alzheimer's amyloid beta-peptide (1-42)-induced neuronal protein oxidation and reactive oxygen species production. J Alzheimer's Dis 2: 123-131.
22. Zhang Z, Drzewiecki GJ, Horn JT, May PC, Hyslop PA (1994) Human cortical neuronal (HCN) cell lines: a model for amyloid beta neurotoxicity. Neurosci Lett 177: 162-164.